| GO ID | GO:0030198 |
| Ontology | BP |
| GO Term | extracellular matrix organization |
| Definition | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
ADAMTS20 | ADAM metallopeptidase with thrombospondin type 1 motif 20 |
80070 | P59510 | chr12: 43,353,866-43,551,921 |
ADAMTSL4 | ADAMTS like 4 |
54507 | Q6UY14 | chr1: 150,549,369-150,560,937 |
APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 |
323 | Q92870 | chr4: 40,810,027-41,216,714 |
APP | amyloid beta (A4) precursor protein |
351 | P05067 | chr21: 25,880,550-26,171,128 |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
2683 | P15291 | chr9: 33,104,082-33,167,356 |
BCAN | brevican |
63827 | Q96GW7 | chr1: 156,641,390-156,659,532 |
BCL3 | B-cell CLL/lymphoma 3 |
602 | P20749 | chr19: 44,747,705-44,760,044 |
BGN | biglycan |
633 | P21810 | chrX: 153,494,939-153,509,554 |
BSG | basigin (Ok blood group) |
682 | P35613 | chr19: 571,277-583,493 |
CCDC80 | coiled-coil domain containing 80 |
151887 | Q76M96 | chr3: 112,596,794-112,649,530 |
CD44 | CD44 molecule (Indian blood group) |
960 | P16070 | chr11: 35,138,870-35,232,402 |
CD47 | CD47 molecule |
961 | Q08722 | chr3: 108,043,298-108,091,025 |
COL10A1 | collagen, type X, alpha 1 |
1300 | Q03692 | chr6: 116,118,923-116,158,747 |
COL11A1 | collagen, type XI, alpha 1 |
1301 | P12107 | chr1: 102,876,467-103,108,496 |
COL13A1 | collagen, type XIII, alpha 1 |
1305 | Q5TAT6 | chr10: 69,801,931-69,964,275 |
COL14A1 | collagen, type XIV, alpha 1 |
7373 | Q05707 | chr8: 120,059,780-120,372,036 |
COL16A1 | collagen, type XVI, alpha 1 |
1307 | Q07092 | chr1: 31,652,247-31,704,319 |
COL18A1 | collagen, type XVIII, alpha 1 |
80781 | P39060 | chr21: 45,405,137-45,513,720 |
COL1A1 | collagen, type I, alpha 1 |
1277 | P02452 | chr17: 50,183,289-50,201,632 |
COL1A2 | collagen, type I, alpha 2 |
1278 | P08123 | chr7: 94,394,561-94,431,232 |
COL3A1 | collagen, type III, alpha 1 |
1281 | P02461 | chr2: 188,974,320-189,012,746 |
COL4A2 | collagen, type IV, alpha 2 |
1284 | P08572 | chr13: 110,305,812-110,513,027 |
COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) |
1285 | Q01955 | chr2: 227,164,565-227,314,792 |
COL4A6 | collagen, type IV, alpha 6 |
1288 | Q14031 | chrX: 108,155,607-108,439,497 |
COL5A1 | collagen, type V, alpha 1 |
1289 | P20908 | chr9: 134,641,774-134,844,843 |
COL5A2 | collagen, type V, alpha 2 |
1290 | P05997 | chr2: 189,031,896-189,179,879 |
COL5A3 | collagen, type V, alpha 3 |
50509 | P25940 | chr19: 9,959,561-10,010,471 |
COL6A1 | collagen, type VI, alpha 1 |
1291 | P12109 | chr21: 45,981,737-46,005,050 |
COL6A2 | collagen, type VI, alpha 2 |
1292 | P12110 | chr21: 46,098,097-46,132,849 |
COL6A3 | collagen, type VI, alpha 3 |
1293 | P12111 | chr2: 237,324,003-237,414,375 |
COL8A2 | collagen, type VIII, alpha 2 |
1296 | P25067 | chr1: 36,095,236-36,125,220 |
COL9A1 | collagen, type IX, alpha 1 |
1297 | P20849 | chr6: 70,215,061-70,303,083 |
COMP | cartilage oligomeric matrix protein |
1311 | P49747 | chr19: 18,782,773-18,791,314 |
CRISPLD2 | cysteine-rich secretory protein LCCL domain containing 2 |
83716 | Q9H0B8 | chr16: 84,819,984-84,920,768 |
CSGALNACT1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
55790 | Q8TDX6 | chr8: 19,404,161-19,758,029 |
CYR61 | cysteine-rich, angiogenic inducer, 61 |
3491 | O00622 | chr1: 85,580,761-85,583,962 |
DAG1 | dystroglycan 1 |
1605 | Q14118 | chr3: 49,468,703-49,535,618 |
DCN | decorin |
1634 | P07585 | chr12: 91,140,484-91,183,123 |
DDR1 | discoidin domain receptor tyrosine kinase 1 |
780 | Q08345 | chr6: 30,876,421-30,900,156 |
DNAJB6 | DnaJ heat shock protein family (Hsp40) member B6 |
10049 | O75190 | chr7: 157,335,381-157,417,439 |
DSPP | dentin sialophosphoprotein |
1834 | Q9NZW4 | chr4: 87,608,529-87,616,910 |
ECM2 | extracellular matrix protein 2, female organ and adipocyte specific |
1842 | O94769 | chr9: 92,493,554-92,536,655 |
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
1999 | P78545 | chr1: 202,007,945-202,017,188 |
ERCC2 | excision repair cross-complementation group 2 |
2068 | P18074 | chr19: 45,349,837-45,370,918 |
ERO1A | endoplasmic reticulum oxidoreductase alpha |
30001 | Q96HE7 | chr14: 52,639,916-52,695,900 |
ERO1B | endoplasmic reticulum oxidoreductase beta |
56605 | Q86YB8 | chr1: 236,215,555-236,281,985 |
F11R | F11 receptor |
50848 | Q9Y624 | chr1: 160,995,211-161,021,348 |
FBLN1 | fibulin 1 |
2192 | P23142 | chr22: 45,502,238-45,601,135 |
FBN1 | fibrillin 1 |
2200 | P35555 | chr15: 48,408,306-48,645,849 |
FBN2 | fibrillin 2 |
2201 | P35556 | chr5: 128,257,909-128,659,185 |
FGA | fibrinogen alpha chain |
2243 | P02671 | chr4: 154,583,126-154,590,766 |
FGB | fibrinogen beta chain |
2244 | P02675 | chr4: 154,562,956-154,571,086 |
FGF2 | fibroblast growth factor 2 (basic) |
2247 | P09038 | chr4: 122,826,708-122,898,236 |
FGG | fibrinogen gamma chain |
2266 | P02679 | chr4: 154,604,134-154,612,967 |
FN1 | fibronectin 1 |
2335 | P02751 | chr2: 215,360,440-215,436,172 |
FURIN | furin (paired basic amino acid cleaving enzyme) |
5045 | P09958 | chr15: 90,868,592-90,883,458 |
HAPLN1 | hyaluronan and proteoglycan link protein 1 |
1404 | P10915 | chr5: 83,637,805-83,721,613 |
HPSE | heparanase |
10855 | Q9Y251 | chr4: 83,292,461-83,335,153 |
HSD17B12 | hydroxysteroid (17-beta) dehydrogenase 12 |
51144 | Q53GQ0 | chr11: 43,680,558-43,856,617 |
HSPG2 | heparan sulfate proteoglycan 2 |
3339 | P98160 | chr1: 21,822,245-21,937,297 |
ICAM1 | intercellular adhesion molecule 1 |
3383 | P05362 | chr19: 10,270,835-10,286,615 |
ITGA10 | integrin subunit alpha 10 |
8515 | O75578 | chr1: 145,891,208-145,910,189 |
ITGA11 | integrin subunit alpha 11 |
22801 | Q9UKX5 | chr15: 68,296,533-68,432,162 |
ITGA2 | integrin subunit alpha 2 |
3673 | P17301 | chr5: 52,989,326-53,094,779 |
ITGA3 | integrin subunit alpha 3 |
3675 | P26006 | chr17: 50,055,968-50,090,481 |
ITGA5 | integrin subunit alpha 5 |
3678 | P08648 | chr12: 54,395,261-54,419,460 |
ITGA6 | integrin subunit alpha 6 |
3655 | P23229 | chr2: 172,427,354-172,506,282 |
ITGA9 | integrin subunit alpha 9 |
3680 | Q13797 | chr3: 37,452,115-37,823,514 |
ITGAE | integrin subunit alpha E |
3682 | P38570 | chr17: 3,714,628-3,801,243 |
ITGAM | integrin subunit alpha M |
3684 | P11215 | chr16: 31,259,990-31,332,892 |
ITGAV | integrin subunit alpha V |
3685 | P06756 | chr2: 186,590,065-186,680,901 |
ITGAX | integrin subunit alpha X |
3687 | P20702 | chr16: 31,355,134-31,382,997 |
ITGB1 | integrin subunit beta 1 |
3688 | P05556 | chr10: 32,900,319-33,005,792 |
ITGB2 | integrin subunit beta 2 |
3689 | P05107 | chr21: 44,885,953-44,931,989 |
ITGB3 | integrin subunit beta 3 |
3690 | P05106 | chr17: 47,253,846-47,311,816 |
ITGB4 | integrin subunit beta 4 |
3691 | P16144 | chr17: 75,721,328-75,757,818 |
ITGB5 | integrin subunit beta 5 |
3693 | P18084 | chr3: 124,761,948-124,901,418 |
ITGB8 | integrin subunit beta 8 |
3696 | P26012 | chr7: 20,330,702-20,415,754 |
JAM2 | junctional adhesion molecule 2 |
58494 | P57087 | chr21: 25,639,272-25,717,562 |
JAM3 | junctional adhesion molecule 3 |
83700 | Q9BX67 | chr11: 134,068,925-134,152,001 |
KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 |
81621 | Q96I82 | chr10: 101,061,841-101,068,131 |
LAMA2 | laminin subunit alpha 2 |
3908 | P24043 | chr6: 128,883,141-129,516,569 |
LAMA3 | laminin subunit alpha 3 |
3909 | Q16787 | chr18: 23,689,443-23,955,066 |
LAMA4 | laminin subunit alpha 4 |
3910 | Q16363 | chr6: 112,108,760-112,254,939 |
LAMB1 | laminin subunit beta 1 |
3912 | P07942 | chr7: 107,923,799-108,003,255 |
LAMC1 | laminin subunit gamma 1 |
3915 | P11047 | chr1: 183,023,460-183,145,592 |
LAMC3 | laminin subunit gamma 3 |
10319 | Q9Y6N6 | chr9: 131,009,082-131,094,473 |
LOX | lysyl oxidase |
4015 | P28300 | chr5: 122,063,195-122,078,360 |
LOXL1 | lysyl oxidase like 1 |
4016 | Q08397 | chr15: 73,925,989-73,952,137 |
LUM | lumican |
4060 | P51884 | chr12: 91,102,629-91,111,831 |
MFAP2 | microfibrillar associated protein 2 |
4237 | P55001 | chr1: 16,974,502-16,980,835 |
MFAP5 | microfibrillar associated protein 5 |
8076 | Q13361 | chr12: 8,637,346-8,662,888 |
NCAN | neurocan |
1463 | O14594 | chr19: 19,211,973-19,252,233 |
NDNF | neuron-derived neurotrophic factor |
79625 | Q8TB73 | chr4: 121,035,613-121,073,021 |
NID1 | nidogen 1 |
4811 | P14543 | chr1: 235,975,830-236,065,162 |
NID2 | nidogen 2 |
22795 | Q14112 | chr14: 52,004,803-52,069,228 |
NPHP3 | nephronophthisis 3 (adolescent) |
27031 | Q7Z494 | chr3: 132,680,609-132,722,442 |
OLFML2A | olfactomedin like 2A |
169611 | Q68BL7 | chr9: 124,777,158-124,814,885 |
PDGFA | platelet-derived growth factor alpha polypeptide |
5154 | P04085 | chr7: 497,258-520,296 |
PDGFB | platelet-derived growth factor beta polypeptide |
5155 | P01127 | chr22: 39,223,359-39,244,751 |
PECAM1 | platelet/endothelial cell adhesion molecule 1 |
5175 | P16284 | chr17: 64,319,415-64,413,776 |
POMT1 | protein-O-mannosyltransferase 1 |
10585 | Q9Y6A1 | chr9: 131,502,902-131,523,806 |
POSTN | periostin, osteoblast specific factor |
10631 | Q15063 | chr13: 37,562,583-37,598,844 |
PRDX4 | peroxiredoxin 4 |
10549 | Q13162 | chrX: 23,664,262-23,686,399 |
PTK2 | protein tyrosine kinase 2 |
5747 | Q05397 | chr8: 140,657,900-141,002,216 |
RECK | reversion-inducing-cysteine-rich protein with kazal motifs |
8434 | O95980 | chr9: 36,036,433-36,124,451 |
SERPINB5 | serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
5268 | P36952 | chr18: 63,476,761-63,505,085 |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
5054 | P05121 | chr7: 101,127,089-101,139,266 |
SMOC2 | SPARC related modular calcium binding 2 |
64094 | Q9H3U7 | chr6: 168,441,151-168,673,445 |
SOX9 | SRY-box 9 |
6662 | P48436 | chr17: 72,121,020-72,126,420 |
SPARC | secreted protein, acidic, cysteine-rich (osteonectin) |
6678 | P09486 | chr5: 151,661,096-151,687,165 |
SPOCK2 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
9806 | Q92563 | chr10: 72,059,035-72,089,032 |
SPP1 | secreted phosphoprotein 1 |
6696 | P10451 | chr4: 87,975,650-87,983,426 |
TGFBI | transforming growth factor beta induced |
7045 | Q15582 | chr5: 136,028,895-136,063,818 |
THBS1 | thrombospondin 1 |
7057 | P07996 | chr15: 39,581,079-39,599,466 |
TMPRSS6 | transmembrane protease, serine 6 |
164656 | Q8IU80 | chr22: 37,065,436-37,109,563 |
TNC | tenascin C |
3371 | P24821 | chr9: 115,019,578-115,118,257 |
TNF | tumor necrosis factor |
7124 | P01375 | chr6: 31,575,567-31,578,336 |
TNFRSF11B | tumor necrosis factor receptor superfamily member 11b |
4982 | O00300 | chr8: 118,923,557-118,952,200 |
TNR | tenascin R |
7143 | Q92752 | chr1: 175,315,194-175,743,770 |
TTR | transthyretin |
7276 | P02766 | chr18: 31,591,726-31,599,021 |
VCAM1 | vascular cell adhesion molecule 1 |
7412 | P19320 | chr1: 100,719,742-100,739,045 |
VCAN | versican |
1462 | P13611 | chr5: 83,471,465-83,582,303 |
VTN | vitronectin |
7448 | P04004 | chr17: 28,367,276-28,373,091 |
VWF | von Willebrand factor |
7450 | P04275 | chr12: 5,948,874-6,124,770 |